Preclinical evidence also suggests direct anticancer effects, even in non-obese models, though translational confirmation is needed
Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe
Many cyanobacteria (and microalgae broadly) are safe to eat, though not every strain of cyanobacteria has a GRAS certification.5 Under the GRAS framework, an ingredient has to be demonstrated as safe either through (1) scientific procedures or (2) in the case of a substance used in food prior to January 1, 1958, through experience based on common use in food. For cyanobacteria to be used as a platform for oral GLP-1 delivery, either a GRAS organism like spirulina must serve as the host organism or, if choosing a different species, the manufacturer must prove with adequate in vivo trial data that it is safe to eat
To protect your results and your investment, our team will confirm the best plan during your consultation, including whether non-surgical tightening is appropriate or whether surgical options should be considered for significant excess skin.
Taken together, the results of numerous small studies equivocally suggest that GLP-1 RA treatment in coronary artery disease patients would be beneficial, regardless of the presence of diabetes
These study designs illustrate that the weight loss outcomes reported in these trials reflect a pharmacologic effect in addition to structured lifestyle support
